JP2018520147A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018520147A5 JP2018520147A5 JP2017567249A JP2017567249A JP2018520147A5 JP 2018520147 A5 JP2018520147 A5 JP 2018520147A5 JP 2017567249 A JP2017567249 A JP 2017567249A JP 2017567249 A JP2017567249 A JP 2017567249A JP 2018520147 A5 JP2018520147 A5 JP 2018520147A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- diacid
- crystal
- pharmaceutical composition
- ratio
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562184591P | 2015-06-25 | 2015-06-25 | |
| US62/184,591 | 2015-06-25 | ||
| PCT/US2016/039572 WO2016210418A1 (en) | 2015-06-25 | 2016-06-27 | Pharmaceutical co-crystal composition and use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018520147A JP2018520147A (ja) | 2018-07-26 |
| JP2018520147A5 true JP2018520147A5 (OSRAM) | 2019-07-18 |
| JP6929234B2 JP6929234B2 (ja) | 2021-09-01 |
Family
ID=57586692
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017567249A Expired - Fee Related JP6929234B2 (ja) | 2015-06-25 | 2016-06-27 | 医薬共結晶組成物及びその用途 |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US10428099B2 (OSRAM) |
| EP (1) | EP3297640A4 (OSRAM) |
| JP (1) | JP6929234B2 (OSRAM) |
| KR (1) | KR20180021805A (OSRAM) |
| CN (2) | CN116854745A (OSRAM) |
| AU (1) | AU2016284816B2 (OSRAM) |
| CA (1) | CA2989001A1 (OSRAM) |
| WO (1) | WO2016210418A1 (OSRAM) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6851989B2 (ja) | 2015-05-18 | 2021-03-31 | シン−ナット プロダクツ エンタープライズ エルエルシー | 医薬用共結晶及びその用途 |
| KR20180018800A (ko) | 2015-06-19 | 2018-02-21 | 신-낫 프로덕츠 엔터프라이즈 엘엘씨 | 카보플라틴 계 공-결정의 약제학적 조성물 및 이의 용도 |
| CA2988989A1 (en) | 2015-06-19 | 2016-12-22 | Syn-Nat Products Enterprise LLC | Composition containing carboplatin and use |
| CN116854745A (zh) | 2015-06-25 | 2023-10-10 | 新纳特产品公司 | 药物共晶组合物及其用途 |
| US20200361973A1 (en) * | 2017-11-21 | 2020-11-19 | Medoncare Pharmaceutical Co., Ltd. | Combination product comprising dicycloplatin and preparation method and use thereof |
| EP3845544B1 (en) * | 2018-09-01 | 2023-11-15 | Beijing Showby Pharmaceutical Co., Ltd. | Phosphate of platinum compound and preparation method therefor |
| CN111205332B (zh) * | 2020-02-25 | 2025-03-21 | 华东理工大学 | 奥沙利铂-黄酮药物共晶及其制备方法和应用 |
| CN118302161A (zh) * | 2021-11-26 | 2024-07-05 | 湖南湘源美东医药科技有限公司 | 含有铂类药物或者铂类药物共晶的药物组合物及其用途 |
| CN116617229A (zh) * | 2023-04-11 | 2023-08-22 | 齐泽(云南)生物科技有限公司 | 一种药用化合物的应用 |
| CN116217628B (zh) * | 2023-05-08 | 2023-07-14 | 华东理工常熟研究院有限公司 | 奥沙利铂Pt(IV)配合物的共晶及其制备方法 |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5922689A (en) | 1995-09-11 | 1999-07-13 | Unitech Pharmaceuticals, Inc. | Cisplatin analogs for cancer treatment |
| US6297245B1 (en) | 1998-08-04 | 2001-10-02 | Unitech Pharmaceuticals | Cisplatin and folic acid administered to treat breast cancer |
| KR100317473B1 (ko) * | 1999-05-11 | 2001-12-22 | 이계호 | 신규의 백금(ｉｖ)착제 및 그 제조방법 |
| CN1121380C (zh) | 2000-03-03 | 2003-09-17 | 北京兴大豪斯科技有限公司 | 一种抗肿瘤的双二羧酸二氨络铂衍生物及其药物组合物 |
| AUPQ641100A0 (en) | 2000-03-23 | 2000-04-15 | Australia Nuclear Science & Technology Organisation | Methods of synthesis and use of radiolabelled platinum chemotherapeutic ag ents |
| ATE431352T1 (de) * | 2001-11-30 | 2009-05-15 | Jingzun Wang | Supermolekulare carboplatinderivate, deren herstellung und pharmazeutische zusammensetzungen,die diese als wirkstoffe enthalten, sowie anwendungen der zusammensetzungen |
| US7927613B2 (en) | 2002-02-15 | 2011-04-19 | University Of South Florida | Pharmaceutical co-crystal compositions |
| EP1545519B1 (en) | 2002-08-19 | 2011-03-23 | Pfizer Inc. | Combination therapy for hyperproliferative diseases |
| JP5069905B2 (ja) * | 2003-01-21 | 2012-11-07 | アプテュイト （ウエスト ラファイエット）、エルエルシー | 新規な共結晶化 |
| CA2514733A1 (en) * | 2003-02-28 | 2004-09-16 | Transform Pharmaceuticals, Inc. | Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen |
| WO2004099224A1 (de) | 2003-05-05 | 2004-11-18 | Universität Regensburg | Carboplatin-artige platin (ii)- komplexe |
| JP2007502301A (ja) | 2003-08-13 | 2007-02-08 | ユニバーシティー オブ サウス フロリダ | 腫瘍細胞の増殖を阻害するための方法 |
| CN101972240B (zh) * | 2003-09-04 | 2012-07-25 | 赛福伦公司 | 莫达芬尼组合物 |
| EP1727520A2 (en) * | 2003-12-09 | 2006-12-06 | Medcrystalforms, Llc | Method of preparation of mixed phase co-crystals with active agents |
| US20080161251A1 (en) | 2005-01-21 | 2008-07-03 | Astex Therapeutics Limited | Pharmaceutical Compounds |
| CN101389637A (zh) | 2006-01-30 | 2009-03-18 | 普拉托技术（私有）公司 | 铂(ⅱ)配合物的制备 |
| EP2049109B1 (en) | 2006-08-02 | 2015-11-18 | Sunesis Pharmaceuticals, Inc. | Combined use of (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid and cytarabine (ara-c) for the treatment of leukemia |
| EP2324006B1 (en) | 2008-09-15 | 2014-08-13 | Kasina Laila Innova Pharmaceuticals Private Ltd. | Anti-cancer drugs and uses relating thereto for metastatic malignant melanoma and other cancers |
| CZ302618B6 (cs) | 2009-09-10 | 2011-08-03 | Univerzita Palackého | Cyklobutan-1,1-dikarboxylátokomplexy platiny s deriváty N6-benzyladeninu, zpusoby jejich prípravy a použití techto komplexu jako léciv v protinádorové terapii |
| CN102791294A (zh) * | 2009-12-16 | 2012-11-21 | 布里格姆妇女医院股份有限公司 | 用于多种药物递送的粒子 |
| US20110287110A1 (en) | 2010-04-23 | 2011-11-24 | Mark Wesley Dewhirst | Combination cancer treatment |
| CN102863474A (zh) * | 2011-07-09 | 2013-01-09 | 陈小平 | 一类治疗细胞增殖性疾病的铂化合物、其制备方法和应用 |
| JP5179628B2 (ja) | 2011-07-15 | 2013-04-10 | ユニーテック株式会社 | ４価白金錯体及びそれを含む医薬組成物 |
| CN102993239A (zh) * | 2011-09-19 | 2013-03-27 | 陈小平 | 离去基团含氨基或烷胺基的丁二酸衍生物的铂类化合物 |
| US9220705B2 (en) | 2013-03-07 | 2015-12-29 | James David Hoeschele | Method of treating colorectal cancer |
| PT3424920T (pt) | 2013-10-17 | 2020-07-07 | Vertex Pharma | Co-cristais de (s)-n-metil-8-(1-((2'-metil-[4,5'-bipirimidin]-6-il)amino)propan-2-il)quinolina-4-carboxamida e derivados deuterados dos mesmos como inibidores de adn-pk |
| CN104127402B (zh) | 2014-08-15 | 2019-08-30 | 北京默加农生物技术发展有限公司 | 双环铂在制备抗病毒药物和抗菌药物中的应用 |
| CN106132408B (zh) | 2015-04-10 | 2018-02-13 | 新纳特产品公司 | 一种双环铂的制备方法 |
| KR102569221B1 (ko) | 2015-04-22 | 2023-08-21 | 신-낫 프로덕츠 엔터프라이즈 엘엘씨 | 공결정 조성물 및 그의 약제학적 용도 |
| JP6851989B2 (ja) * | 2015-05-18 | 2021-03-31 | シン−ナット プロダクツ エンタープライズ エルエルシー | 医薬用共結晶及びその用途 |
| KR20180018800A (ko) | 2015-06-19 | 2018-02-21 | 신-낫 프로덕츠 엔터프라이즈 엘엘씨 | 카보플라틴 계 공-결정의 약제학적 조성물 및 이의 용도 |
| CA2988989A1 (en) | 2015-06-19 | 2016-12-22 | Syn-Nat Products Enterprise LLC | Composition containing carboplatin and use |
| CN116854745A (zh) | 2015-06-25 | 2023-10-10 | 新纳特产品公司 | 药物共晶组合物及其用途 |
-
2016
- 2016-06-27 CN CN202310745029.1A patent/CN116854745A/zh active Pending
- 2016-06-27 JP JP2017567249A patent/JP6929234B2/ja not_active Expired - Fee Related
- 2016-06-27 KR KR1020187001706A patent/KR20180021805A/ko not_active Ceased
- 2016-06-27 EP EP16815489.6A patent/EP3297640A4/en not_active Withdrawn
- 2016-06-27 US US15/736,179 patent/US10428099B2/en active Active
- 2016-06-27 AU AU2016284816A patent/AU2016284816B2/en not_active Ceased
- 2016-06-27 WO PCT/US2016/039572 patent/WO2016210418A1/en not_active Ceased
- 2016-06-27 CN CN201680037094.7A patent/CN107847521A/zh active Pending
- 2016-06-27 CA CA2989001A patent/CA2989001A1/en not_active Abandoned
-
2019
- 2019-08-15 US US16/541,504 patent/US20190367547A1/en not_active Abandoned
-
2020
- 2020-12-15 US US17/122,380 patent/US11685757B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6606692B2 (ja) | （２Ｒ，５Ｓ，１３ＡＲ）−８−ヒドロキシ−７，９−ジオキソ−Ｎ−（２，４，６−トリフルオロベンジル）−２，３，４，５，７，９，１３，１３Ａ−オクタヒドロ−２，５−メタノピリド［１’，２’：４，５］ピラジノ［２，１−ｂ］［１，３］オキサゼピン−１０−カルボキサミドの結晶形 | |
| JP2019524883A5 (OSRAM) | ||
| CA2950307C (en) | Sodium (2r,5s,13ar)-7,9-dioxo-10-((2,4,6-trifluorobenzyl)carbamoyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepin-8-olate | |
| JP2016121196A5 (OSRAM) | ||
| JP2013056886A5 (OSRAM) | ||
| JP2016537346A5 (OSRAM) | ||
| JP2017512186A5 (OSRAM) | ||
| JP2014507421A5 (OSRAM) | ||
| JP2014503525A5 (OSRAM) | ||
| JP2015038149A5 (OSRAM) | ||
| JP2010500293A5 (OSRAM) | ||
| JP2018504378A5 (OSRAM) | ||
| JP2020517611A5 (OSRAM) | ||
| JP2017515901A5 (OSRAM) | ||
| JP2013519632A5 (OSRAM) | ||
| ME02612B (me) | Tenofovir alafenamid hemifumarat | |
| JP2019504103A5 (OSRAM) | ||
| JP2018521969A5 (OSRAM) | ||
| JP2012526808A5 (OSRAM) | ||
| CN116854745A (zh) | 药物共晶组合物及其用途 | |
| JP2018521969A (ja) | 医薬用共結晶及びその用途 | |
| JP2019516749A5 (OSRAM) | ||
| JP2018524320A5 (OSRAM) | ||
| CN106687470A (zh) | 结晶形式的索非布韦及其制备方法 | |
| JP6872179B2 (ja) | テノホビルプロドラッグの新規な多結晶形並びにその製造方法及び用途 |